527 related articles for article (PubMed ID: 7723794)
1. Mutation of the androgen-receptor gene in metastatic androgen-independent prostate cancer.
Taplin ME; Bubley GJ; Shuster TD; Frantz ME; Spooner AE; Ogata GK; Keer HN; Balk SP
N Engl J Med; 1995 May; 332(21):1393-8. PubMed ID: 7723794
[TBL] [Abstract][Full Text] [Related]
2. Frequent detection of codon 877 mutation in the androgen receptor gene in advanced prostate cancers.
Gaddipati JP; McLeod DG; Heidenberg HB; Sesterhenn IA; Finger MJ; Moul JW; Srivastava S
Cancer Res; 1994 Jun; 54(11):2861-4. PubMed ID: 8187068
[TBL] [Abstract][Full Text] [Related]
3. Transcriptional regulation of the androgen signaling pathway by the Wilms' tumor suppressor gene WT1.
Zaia A; Fraizer GC; Piantanelli L; Saunders GF
Anticancer Res; 2001; 21(1A):1-10. PubMed ID: 11299720
[TBL] [Abstract][Full Text] [Related]
4. Activation of two mutant androgen receptors from human prostatic carcinoma by adrenal androgens and metabolic derivatives of testosterone.
Culig Z; Stober J; Gast A; Peterziel H; Hobisch A; Radmayr C; Hittmair A; Bartsch G; Cato AC; Klocker H
Cancer Detect Prev; 1996; 20(1):68-75. PubMed ID: 8907206
[TBL] [Abstract][Full Text] [Related]
5. Bone extracellular matrix induces homeobox proteins independent of androgens: possible mechanism for androgen-independent growth in human prostate cancer cells.
Robbins SE; Shu WP; Kirschenbaum A; Levine AC; Miniati DN; Liu BC
Prostate; 1996 Dec; 29(6):362-70. PubMed ID: 8977633
[TBL] [Abstract][Full Text] [Related]
6. Androgen deprivation induces selective outgrowth of aggressive hormone-refractory prostate cancer clones expressing distinct cellular and molecular properties not present in parental androgen-dependent cancer cells.
Tso CL; McBride WH; Sun J; Patel B; Tsui KH; Paik SH; Gitlitz B; Caliliw R; van Ophoven A; Wu L; deKernion J; Belldegrun A
Cancer J; 2000; 6(4):220-33. PubMed ID: 11038142
[TBL] [Abstract][Full Text] [Related]
7. Polymorphisms of human androgen receptor (hAR) gene in prostate cancer cell lines PC-EW and PC-OR.
Engehausen DG; Krause FS; Fleischmann J; Akcetin Z; Schrott KM; Endele S
Anticancer Res; 2005; 25(3A):1611-4. PubMed ID: 16033069
[TBL] [Abstract][Full Text] [Related]
8. Mutations in the androgen receptor gene are associated with progression of human prostate cancer to androgen independence.
Tilley WD; Buchanan G; Hickey TE; Bentel JM
Clin Cancer Res; 1996 Feb; 2(2):277-85. PubMed ID: 9816170
[TBL] [Abstract][Full Text] [Related]
9. Transfected neu oncogene induces human prostate cancer metastasis.
Zhau HY; Zhou J; Symmans WF; Chen BQ; Chang SM; Sikes RA; Chung LW
Prostate; 1996 Feb; 28(2):73-83. PubMed ID: 8604395
[TBL] [Abstract][Full Text] [Related]
10. Increased expression of genes converting adrenal androgens to testosterone in androgen-independent prostate cancer.
Stanbrough M; Bubley GJ; Ross K; Golub TR; Rubin MA; Penning TM; Febbo PG; Balk SP
Cancer Res; 2006 Mar; 66(5):2815-25. PubMed ID: 16510604
[TBL] [Abstract][Full Text] [Related]
11. Collocation of androgen receptor gene mutations in prostate cancer.
Buchanan G; Greenberg NM; Scher HI; Harris JM; Marshall VR; Tilley WD
Clin Cancer Res; 2001 May; 7(5):1273-81. PubMed ID: 11350894
[TBL] [Abstract][Full Text] [Related]
12. Hyperactive androgen receptor in prostate cancer: what does it mean for new therapy concepts?
Culig Z; Hobisch A; Hittmair A; Peterziel H; Radmayr C; Bartsch G; Cato AC; Klocker H
Histol Histopathol; 1997 Jul; 12(3):781-6. PubMed ID: 9225161
[TBL] [Abstract][Full Text] [Related]
13. [Androgen receptor gene mutations and p53 gene analysis in advanced prostate cancer].
Castagnaro M; Yandell DW; Dockhorn-Dworniczak B; Wolfe HJ; Poremba C
Verh Dtsch Ges Pathol; 1993; 77():119-23. PubMed ID: 7511268
[TBL] [Abstract][Full Text] [Related]
14. Elevated E2F1 inhibits transcription of the androgen receptor in metastatic hormone-resistant prostate cancer.
Davis JN; Wojno KJ; Daignault S; Hofer MD; Kuefer R; Rubin MA; Day ML
Cancer Res; 2006 Dec; 66(24):11897-906. PubMed ID: 17178887
[TBL] [Abstract][Full Text] [Related]
15. Characterization of a novel androgen receptor mutation in a relapsed CWR22 prostate cancer xenograft and cell line.
Tepper CG; Boucher DL; Ryan PE; Ma AH; Xia L; Lee LF; Pretlow TG; Kung HJ
Cancer Res; 2002 Nov; 62(22):6606-14. PubMed ID: 12438256
[TBL] [Abstract][Full Text] [Related]
16. Mutation screening of the androgen receptor promoter and untranslated regions in prostate cancer.
Waltering KK; Wallén MJ; Tammela TL; Vessella RL; Visakorpi T
Prostate; 2006 Nov; 66(15):1585-91. PubMed ID: 16927275
[TBL] [Abstract][Full Text] [Related]
17. Coexpression of the partial androgen receptor enhances the efficacy of prostate-specific antigen promoter-driven suicide gene therapy for prostate cancer cells at low testosterone concentrations.
Suzuki S; Tadakuma T; Asano T; Hayakawa M
Cancer Res; 2001 Feb; 61(4):1276-9. PubMed ID: 11245419
[TBL] [Abstract][Full Text] [Related]
18. Germline mutation analysis of the androgen receptor gene in Finnish patients with prostate cancer.
Koivisto PA; Hyytinen ER; Matikainen M; Tammela TL; Ikonen T; Schleutker J
J Urol; 2004 Jan; 171(1):431-3. PubMed ID: 14665948
[TBL] [Abstract][Full Text] [Related]
19. Methylation of the androgen receptor minimal promoter silences transcription in human prostate cancer.
Kinoshita H; Shi Y; Sandefur C; Meisner LF; Chang C; Choon A; Reznikoff CR; Bova GS; Friedl A; Jarrard DF
Cancer Res; 2000 Jul; 60(13):3623-30. PubMed ID: 10910077
[TBL] [Abstract][Full Text] [Related]
20. Androgen receptor signaling and vitamin D receptor action in prostate cancer cells.
Murthy S; Agoulnik IU; Weigel NL
Prostate; 2005 Sep; 64(4):362-72. PubMed ID: 15754350
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
